secwatch.observer — SEC 8-K summary
======================================

Issuer:     Petros Pharmaceuticals, Inc. (PTPI)
CIK:        0001815903
Form:       8-K
Filed at:   2024-10-18T23:59:59+00:00
Accession:  0001104659-24-109893
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Petros Pharma reduces President Boctor's base salary to $280K, sets Dec 31 termination
--------------------------------------------------------------------------------

- Base salary cut from $350K to $280K effective Oct 16, 2024.
- Employment termination date set to Dec 31, 2024; at-will status continues.
- Boctor now permitted to engage in other consulting/employment activities if no conflict.
- Amendment approved by Director Josh Silverman.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815903/000110465924109893/0001104659-24-109893-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815903/000110465924109893/tm2426328d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-109893

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer